SHL Telemedicine (NASDAQ:SHLT) Trading Up 11.2% – Should You Buy?

SHL Telemedicine Ltd. (NASDAQ:SHLT)’s share price was up 11.2% during trading on Monday . The stock traded as high as $3.19 and last traded at $3.17. Approximately 6,267 shares traded hands during mid-day trading, an increase of 76% from the average daily volume of 3,568 shares. The stock had previously closed at $2.85.

SHL Telemedicine Price Performance

The firm has a 50 day moving average price of $3.01 and a 200 day moving average price of $4.02. The company has a quick ratio of 1.98, a current ratio of 2.17 and a debt-to-equity ratio of 0.19.

Hedge Funds Weigh In On SHL Telemedicine

A hedge fund recently bought a new stake in SHL Telemedicine stock. Y.D. More Investments Ltd acquired a new stake in shares of SHL Telemedicine Ltd. (NASDAQ:SHLT) in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 2,219,610 shares of the company’s stock, valued at approximately $11,351,000. SHL Telemedicine accounts for approximately 1.2% of Y.D. More Investments Ltd’s investment portfolio, making the stock its 22nd largest holding. Y.D. More Investments Ltd owned 15.12% of SHL Telemedicine as of its most recent filing with the Securities and Exchange Commission (SEC). Institutional investors and hedge funds own 20.11% of the company’s stock.

About SHL Telemedicine

SHL Telemedicine Ltd., together with its subsidiaries, develops and markets personal telemedicine solutions in Israel, Europe, and internationally. It offers smartheart, a personal mobile 12 lead ECG device that enables the detection of heart attacks; CardioSen'C, a personal cellular-digital 12-lead ECG transmitter device; and Cardio'B, a portable device to transmit a 12-lead ECG.